D
Madrigal Pharmaceuticals, Inc. MDGL
$424.00 $11.772.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -42.28M -73.24M -59.42M -106.96M -151.97M
Total Depreciation and Amortization 432.00K 435.00K 363.00K 298.00K 267.00K
Total Amortization of Deferred Charges 371.00K 436.00K 482.00K 480.00K 472.00K
Total Other Non-Cash Items 26.10M 20.93M 17.73M 17.44M 24.40M
Change in Net Operating Assets -31.68M -37.46M -63.65M 21.76M -8.12M
Cash from Operations -47.05M -88.89M -104.49M -66.98M -134.95M
Capital Expenditure -- -- -195.00K -779.00K -131.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 47.86M 163.88M -47.76M -201.61M -121.97M
Cash from Investing 47.86M 163.88M -47.95M -202.39M -122.10M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.74M 8.64M 19.77M 7.46M 134.12M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 1.74M 8.64M 19.77M 7.46M 134.12M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.55M 83.63M -132.67M -261.91M -122.92M